1. Home
  2. PRCH vs ADCT Comparison

PRCH vs ADCT Comparison

Compare PRCH & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Porch Group Inc.

PRCH

Porch Group Inc.

HOLD

Current Price

$8.98

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$3.52

Market Cap

483.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCH
ADCT
Founded
2012
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
483.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PRCH
ADCT
Price
$8.98
$3.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
6
Target Price
$17.56
$7.60
AVG Volume (30 Days)
1.4M
2.0M
Earning Date
11-05-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$442,483,000.00
$75,209,000.00
Revenue This Year
N/A
$10.36
Revenue Next Year
$17.06
$3.87
P/E Ratio
$33.03
N/A
Revenue Growth
N/A
6.35
52 Week Low
$3.72
$1.05
52 Week High
$19.44
$4.80

Technical Indicators

Market Signals
Indicator
PRCH
ADCT
Relative Strength Index (RSI) 34.41 41.62
Support Level $8.81 $3.35
Resistance Level $9.28 $4.05
Average True Range (ATR) 0.50 0.29
MACD 0.09 -0.04
Stochastic Oscillator 6.37 31.20

Price Performance

Historical Comparison
PRCH
ADCT

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: